|
CMPS
|
COMPASS Pathways Plc
|
10.25%
|
US
|
NASDAQ
|
|
CYBN
|
Cybin Inc.
|
10.24%
|
US
|
AMEX
|
|
ATAI
|
ATAI Life Sciences N.V.
|
5.86%
|
US
|
NASDAQ
|
|
SEEL
|
Seelos Therapeutics, Inc.
|
4.96%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
4.70%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
4.70%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
4.70%
|
US
|
NASDAQ
|
|
HUGE
|
FSD Pharma Inc. - Class B Subordinate Voting Shares
|
4.68%
|
US
|
NASDAQ
|
|
GHRS
|
GH Research PLC
|
4.57%
|
US
|
NASDAQ
|
|
RLMD
|
Relmada Therapeutics, Inc.
|
4.36%
|
US
|
NASDAQ
|
|
GBNH
|
Greenbrook TMS Inc.
|
4.32%
|
US
|
NASDAQ
|
|
NUMI
|
Numinus Wellness Inc
|
3.84%
|
CA
|
TSXV
|
|
DMT
|
Small Pharma Inc
|
2.14%
|
CA
|
TSXV
|